In the last trading session, 4.13 million shares of the Kezar Life Sciences Inc (NASDAQ:KZR) were traded, and its beta was 0.21. Most recently the company’s share price was $0.74, and it changed around -$0.03 or -4.39% from the last close, which brings the market valuation of the company to $53.99M. KZR currently trades at a discount to its 52-week high of $1.13, offering almost -52.7% off that amount. The share price’s 52-week low was $0.52, which indicates that the current value has risen by an impressive 29.73% since then. We note from Kezar Life Sciences Inc’s average daily trading volume that its 10-day average is 3.12 million shares, with the 3-month average coming to 692.53K.
Kezar Life Sciences Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 2.33. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 0 recommended KZR as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Kezar Life Sciences Inc is expected to report earnings per share of -0.31 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Kezar Life Sciences Inc (NASDAQ:KZR) trade information
Instantly KZR has showed a red trend with a performance of -4.39% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.8599 on recent trading dayincreased the stock’s daily price by 13.94%. The company’s shares are currently down -21.89% year-to-date, but still down -6.42% over the last five days. On the other hand, Kezar Life Sciences Inc (NASDAQ:KZR) is 30.44% up in the 30-day period. We can see from the shorts that 0.87 million shares have been sold at a short interest cover period of 2.74 day(s).
The consensus price target as assigned by Wall Street analysts is $17.5, which translates to bulls needing to increase their stock price by 95.77% from its current value. Analyst projections state that KZR is forecast to be at a low of $14 and a high of $21.
Kezar Life Sciences Inc (KZR) estimates and forecasts
Kezar Life Sciences Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -10.69 percent over the past six months and at a 8.40% annual growth rate that is well below the industry average of 17.60%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 3.10% in revenue this quarter, and will report an increase of 25.00% in the next quarter. The year-over-year growth rate is expected to be -71.40%, down from the previous year.
Consensus estimates provided by 5 financial analysts predict the company will bring in an average of 800k in revenue for the current quarter. 5 analysts expect Kezar Life Sciences Inc to make 1.6M in revenue for the current ending quarter.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 9.06%.
KZR Dividends
Kezar Life Sciences Inc’s next quarterly earnings report is expected to be released in November.
Kezar Life Sciences Inc (NASDAQ:KZR)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 14.79% of Kezar Life Sciences Inc shares, and 54.08% of them are in the hands of institutional investors. The stock currently has a share float of 63.47%. Kezar Life Sciences Inc stock is held by 92.0 institutions, with SUVRETTA CAPITAL MANAGEMENT, LLC being the largest institutional investor. By 2024-06-30, it held 9.8456% of the shares, which is about 7.17 million shares worth $4.3 million.
AVIDITY PARTNERS MANAGEMENT LP, with 6.9039% or 5.03 million shares worth $3.02 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
